文献速递神经MR

MRI评估的脑与上颈髓萎缩与肌萎缩侧索硬化疾病侵袭性的关联

Association between brain and upper cervical spinal cord atrophy assessed by MRI and disease aggressiveness in amyotrophic lateral sclerosis.
PubMed 文献 · Neuroradiology · 2023-07-17

研究纳入29例ALS患者和24名年龄性别匹配的健康对照,用3D-T1加权MRI测量脑灰质、白质、脑干亚结构体积及C1-C2水平脊髓横截面积。快速进展者较健康对照出现显著灰质、延髓和脊髓萎缩,且灰质萎缩较慢速进展者显著;灰质体积与ALSFRS-R进展率及3、6个月ALSFRS-R相关。MRI指标对区分快速与慢速进展者表现良好,提示分室萎缩与疾病侵袭性相关。

要点

  • 快速进展者较健康对照可见灰质、延髓及C1-C2脊髓横截面积显著萎缩。
  • 快速进展者灰质萎缩较慢速进展者显著,灰质体积与ALSFRS-R进展率相关。
  • 延髓体积和脊髓横截面积与3个月ALSFRS-R相关。

核心结论

  • 本研究提示分室萎缩与疾病侵袭性存在关联,与上下运动神经元变性共同驱动ALS病情恶化与严重度的观点一致,并凸显MRI测量的脑与脊髓萎缩作为疾病侵袭性特征生物标志物的潜力。

研究设计与样本

  • 研究纳入29例ALS患者与24名年龄和性别匹配的健康对照,采用3D-T1加权MRI测量脑灰质、白质、脑干亚结构体积及C1-C2椎体水平脊髓横截面积,并评估基线、3个月和6个月随访的疾病 duration 与修订版ALS功能评定量表(ALSFRS-R)。

关键影像表现/征象

  • 快速进展者较健康对照显示显著灰质萎缩(p<0.001)、延髓萎缩(p=0.013)和脊髓萎缩(p=0.008)。
  • 快速进展者较慢速进展者显示显著灰质萎缩(p=0.008)。

诊断标准与关键数值

  • 根据ALSFRS-R进展率将患者分为快速进展者(n=13)和慢速进展者(n=16)。
  • 灰质体积与ALSFRS-R进展率相关(Rho/p=-0.487/0.007),与3个月ALSFRS-R相关(Rho/p=0.622/0.002),与6个月ALSFRS-R相关(Rho/p=0.407/0.039)。
  • 延髓体积与3个月ALSFRS-R相关(Rho/p=0.510/0.015),脊髓横截面积与3个月ALSFRS-R相关(Rho/p=0.479/0.024)。
  • MRI指标对区分快速与慢速进展者表现出高判别性能(原文未报告具体敏感度、特异度或AUC数值)。

临床应用与阅片要点

  • 阅片时可关注脑灰质、延髓体积及C1-C2水平脊髓横截面积的萎缩改变,这些指标与ALS疾病进展速度相关。
  • 原文指出MRI测量的脑与脊髓萎缩有潜力作为疾病侵袭性特征的生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To study the relative contributions of brain and upper cervical spinal cord compartmental atrophy to disease aggressiveness in amyotrophic lateral sclerosis (ALS).

METHODS: Twenty-nine ALS patients and 24 age- and gender-matched healthy controls (HC) were recruited. Disease duration and the Revised-ALS Functional Rating Scale (ALSFRS-R) at baseline, 3- and 6-months follow-up were assessed. Patients were clinically differentiated into fast (n=13) and slow (n=16) progressors according to their ALSFRS-R progression rate. Brain grey (GM) and white matter, brainstem sub-structures volumes and spinal cord cross-sectional area (SC-CSA) at C1-C2 vertebral levels were measured from a 3D-T1-weighted MRI.

RESULTS: Fast progressors showed significant GM, medulla oblongata and SC atrophy compared to HC (p<0.001, p=0.013 and p=0.008) and significant GM atrophy compared to slow progressors (p=0.008). GM volume correlated with the ALSFRS-R progression rate (Rho/p=-0.487/0.007), the ALSFRS-R at 3-months (Rho/p=0.622/0.002), and ALSFRS-R at 6-months (Rho/p=0.407/0.039). Medulla oblongata volume and SC-CSA correlated with the ALSFRS-R at 3-months (Rho/p=0.510/0.015 and Rho/p=0.479/0.024). MRI measures showed high performance to discriminate between fast and slow progressors.

CONCLUSION: Our study suggests an association between compartmental atrophy and disease aggressiveness. This result is consistent with the combination of upper and lower motor neuron degeneration as the main driver of disease worsening and severity in ALS. Our study highlights the potential of brain and spinal cord atrophy measured by MRI as biomarker of disease aggressiveness signature.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. El Mendili MM, Verschueren A, Ranjeva JP, et al. Association between brain and upper cervical spinal cord atrophy assessed by MRI and disease aggressiveness in amyotrophic lateral sclerosis. Neuroradiology. 2023. PMID: 37458788. doi:10.1007/s00234-023-03191-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。